A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

Clinical trial NCT06735248 · RECRUITING

Trial details

NCT number: NCT06735248
Sponsor: ModernaTX, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2025-04-16
Primary completion: 2029-01-08
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.